» Articles » PMID: 10339573

E-cadherin Induces Mesenchymal-to-epithelial Transition in Human Ovarian Surface Epithelium

Overview
Specialty Science
Date 1999 May 26
PMID 10339573
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

Ovarian carcinomas are thought to arise in the ovarian surface epithelium (OSE). Although this tissue forms a simple epithelial covering on the ovarian surface, OSE cells exhibit some mesenchymal characteristics and contain little or no E-cadherin. However, E-cadherin is present in metaplastic OSE cells that resemble the more complex epithelia of the oviduct, endometrium and endocervix, and in primary epithelial ovarian carcinomas. To determine whether E-cadherin was a cause or consequence of OSE metaplasia, we expressed this cell-adhesion molecule in simian virus 40-immortalized OSE cells. In these cells the exogenous E-cadherin, all three catenins, and F-actin localized at sites of cell-cell contact, indicating the formation of functional adherens junctions. Unlike the parent OSE cell line, which had undergone a typical mesenchymal transformation in culture, E-cadherin-expressing cells contained cytokeratins and the tight-junction protein occludin. They also formed cobblestone monolayers in two-dimensional culture and simple epithelia in three-dimensional culture that produced CA125 and shed it into the culture medium. CA125 is a normal epithelial-differentiation product of the oviduct, endometrium, and endocervix, but not of normal OSE. It is also a tumor antigen that is produced by ovarian neoplasms and by metaplastic OSE. Thus, E-cadherin restored some normal characteristics of OSE, such as keratin, and it also induced epithelial-differentiation markers associated with weakly preneoplastic, metaplastic OSE and OSE-derived primary carcinomas. The results suggest an unexpected role for E-cadherin in ovarian neoplastic progression.

Citing Articles

Exploring the characteristics of immortalized human ovarian surface epithelial cell lines.

Shin H, Yang W, Kim J, Chang H, Yoo J, Choi W Heliyon. 2025; 11(4):e42539.

PMID: 40034272 PMC: 11874562. DOI: 10.1016/j.heliyon.2025.e42539.


The Role of Endothelial-to-Mesenchymal Transition in Cardiovascular Disease.

Peng Q, Shan D, Cui K, Li K, Zhu B, Wu H Cells. 2022; 11(11).

PMID: 35681530 PMC: 9180466. DOI: 10.3390/cells11111834.


NGF/TRKA Promotes ADAM17-Dependent Cleavage of P75 in Ovarian Cells: Elucidating a Pro-Tumoral Mechanism.

Garrido M, Vallejos C, Girardi S, Gabler F, Selman A, Lopez F Int J Mol Sci. 2022; 23(4).

PMID: 35216240 PMC: 8877415. DOI: 10.3390/ijms23042124.


Prognostic and Clinicopathological Significance of the Aberrant Expression of β-Catenin in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Ramos-Garcia P, Gonzalez-Moles M Cancers (Basel). 2022; 14(3).

PMID: 35158747 PMC: 8833491. DOI: 10.3390/cancers14030479.


Plant-Derived Chinese Medicine Monomers on Ovarian Cancer via the Wnt/-Catenin Signaling Pathway: Review of Mechanisms and Prospects.

Xu J, Liu F, Liu S, Xie L, Li J, Ma Y J Oncol. 2021; 2021:6852867.

PMID: 34912456 PMC: 8668291. DOI: 10.1155/2021/6852867.


References
1.
Southern P, Berg P . Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet. 1982; 1(4):327-41. View

2.
Rubinfeld B, Robbins P, Albert I, Porfiri E, Polakis P . Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science. 1997; 275(5307):1790-2. DOI: 10.1126/science.275.5307.1790. View

3.
Davis H, Zurawski Jr V, Bast Jr R, Klug T . Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas. Cancer Res. 1986; 46(12 Pt 1):6143-8. View

4.
Nose A, Nagafuchi A, Takeichi M . Expressed recombinant cadherins mediate cell sorting in model systems. Cell. 1988; 54(7):993-1001. DOI: 10.1016/0092-8674(88)90114-6. View

5.
Shimoyama Y, Hirohashi S, Hirano S, Noguchi M, Shimosato Y, Takeichi M . Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res. 1989; 49(8):2128-33. View